In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker
- 31 July 2005
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 32 (5) , 431-436
- https://doi.org/10.1016/j.nucmedbio.2005.03.005
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Influence of farnesyl transferase inhibitor treatment on epidermal growth factor receptor statusNuclear Medicine and Biology, 2004
- Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphyAnnals of Oncology, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Molecular ImagingRadiology, 2001
- Characterization of123I-vascular endothelial growth factor-binding sites expressed on human tumour cells: Possible implication for tumour scintigraphyInternational Journal of Cancer, 2001
- Nuclear imaging methods for non-invasive drug monitoringAdvanced Drug Delivery Reviews, 2000
- 4. Synthesis, biodistribution and dosimetry studies of 123I-labelled Annexin V in mice: A potential SPET-ligand for visualisation of apoptotic cellsNuclear Medicine Communications, 1999
- In vivo evaluation in mice and metabolism in blood of human volunteers of [ 123 I]iodo-PK11195: a possible single-photon emission tomography tracer for visualization of inflammationEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997